The Library
1530 papers on microsampling and monitoring, each with a finding paraphrased to our standard and labelled in one vocabulary. Every entry links to a legitimate copy; nothing is copied from an abstract.
Papers 101–184 of 184 labelled “neoteryx-mitra”, newest first.
2023
Microsampling assays for immunosuppressant monitoring showed three- to fourfold higher imprecision across 14 laboratories than conventional whole-blood analysis, with coefficients of variation of 11.7 to 18.6 percent versus 3.9 to 4.9 percent. In a patient specimen, this analytical scatter produced a different clinical decision, proving that current microsampling practice lacks the standardisation required for safe home-based therapeutic drug monitoring.
Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays — Veenhof et al., Therapeutic drug monitoring
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- tdm
- immunosuppressants
2023
The study developed and validated a LC-MS/MS assay for imatinib and its metabolite using volumetric absorptive microsampling, enabling reliable home blood collection by patients with chronic myeloid leukaemia. Therapeutic drug concentrations measured from VAMS were comparable across adherence groups, supporting the use of VAMS for routine decentralised monitoring of imatinib therapy.
Volumetric dried blood microsampling for monitoring imatinib mesylate therapy: Method development and clinical application in patients with chronic myeloid leukemia — Krützmann et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- self-collection
- validation
- tdm
- oncology
2023
Room temperature storage of dried blood on VAMS devices caused significant losses in 13 of 21 cytokine analytes after five months compared to storage at 4 °C. Storing devices at 4 °C or colder preserved the majority of tested cytokines, demonstrating that cold storage is essential for reliable longitudinal cytokine profiling in decentralised studies.
Stability of inflammation markers in human blood collected using volumetric absorptive microsampling (VAMS) under typical laboratory storage temperatures — McMahon et al., Cytokine (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- biomarkers
2023
The review found that volumetric absorptive microsampling can reliably assay tacrolimus and mycophenolic acid for therapeutic drug monitoring, though correction factors are often required to meet regulatory agreement standards. This supports the use of microsampling for decentralised trials and dose optimisation in transplant recipients.
Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment — Leino et al., Therapeutic drug monitoring (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2022
This review shows that patient-centric Mitra microsampling devices accurately collect fixed blood volumes for immunosuppressant monitoring, reducing haematocrit bias compared to classic dried blood spots. While ideal for paediatric adherence, wider decentralised adoption requires further multicentre validation and cross-laboratory harmonisation to address current analytical and cost limitations.
Volumetric Absorptive Microsampling in Therapeutic Drug Monitoring of Immunosuppressive Drugs — From Sampling and Analytical Issues to Clinical Application — Kocur & Pawiński, Int. J. Molecular Sciences
- vams
- neoteryx-mitra
- blood
- tdm
- haematocrit
- dried
- pediatric
- immunosuppressants
- validation
2022
Clinical validation for tacrolimus and mycophenolic acid monitoring showed that while volumetric absorptive microsampling met analytical criteria after concentration correction, conventional dried blood spots achieved superior adherence to strict clinical criteria, sample quality, and cost efficiency without significant haematocrit bias.
Comparison of conventional dried blood spots and volumetric absorptive microsampling for tacrolimus and mycophenolic acid determination — Paniagua-González et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- capillary
- vams
- dbs
- neoteryx-mitra
- self-collection
- validation
- venous-agreement
- tdm
- immunosuppressants
- economics
- haematocrit
2022
A validated LC-MS/MS assay for furosemide in whole blood collected with volumetric absorptive microsampling (10 µL) showed stability for 161 days when stored dried at -78°C, enabling decentralised therapeutic drug monitoring in neonates and children.
A whole blood microsampling furosemide assay: development, validation and use in a pediatric pharmacokinetic study — Bamat et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- pediatric
- tdm
2022
The study found that acetylsalicylic acid recovered poorly from VAMS blood samples dried at room temperature, reaching only about 31% of the concentration measured in venous control samples, but humidity-controlled drying raised recovery above 85%. A household vacuum sealer achieved adequate humidity control at home, supporting the feasibility of decentralised, patient-centric blood sampling for acetylsalicylic acid monitoring.
Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions — Moon et al., Translational and clinical pharmacology
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- dct
2022
LC-MS/MS assays successfully validated the quantitation of giredestrant in dried whole blood across 1 to 1000 ng/ml using Mitra and Tasso-M20 microsampling devices. Quantitation was unaffected by haematocrit, hyperlipidaemia or anticoagulants, with ambient stability documented for 84 days on Mitra and 28 days on Tasso-M20.
Volumetric absorptive microsampling-LC-MS/MS assays for quantitation of giredestrant in dried human whole blood — Johnson et al., Bioanalysis (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- tdm
- oncology
- haematocrit
2022
Neoteryx Mitra sticks and Noviplex cards agreed more closely with venous plasma and gave more repeatable N-glycoprofiling results than dried blood spots, with relative deviance from plasma of 0.092 and 0.069 respectively compared with 0.674 for dried blood spots, and coefficient of variation values of 7.098 per cent and 4.831 per cent against 14.305 per cent for dried blood spots. The findings support these self-sampling devices for decentralised glycoanalysis, though the authors call for larger cohort validation.
Comparison of self-sampling blood collection for N-glycosylation analysis — Cvetko et al., BMC research notes
- blood
- dried
- capillary
- vams
- dbs
- neoteryx-mitra
- validation
- venous-agreement
2022
Volumetric Absorptive Microsampling (VAMS) using Neoteryx Mitra devices yields equivalent results to conventional serum samples for aflatoxin B1-lysine analysis when samples are digested with sufficient Pronase at 50 °C. This enables reliable public health exposure assessment from self-collected dried blood samples.
Optimization of Aflatoxin B<sub>1</sub>-Lysine Analysis for Public Health Exposure Studies — Renaud et al., Toxins
- blood
- dried
- vams
- neoteryx-mitra
- validation
- toxicology
2022
The study found that automating sample preparation for tacrolimus testing on VAMS devices reduced operator time and improved workflow consistency without compromising agreement with manual methods. This supports the scalability of decentralised therapeutic drug monitoring using patient-centric microsampling.
Automation of tacrolimus measurement on volumetric absorptive microsampling devices by tandem mass spectrometry — Carling et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- immunosuppressants
2022
The authors validated an LC-MS and LC-MS/MS method for quantifying axitinib from 10 microlitre capillary blood collected by VAMS, demonstrating within- and between-run precision within 14% CV and accuracy between 81 and 116% against plasma as the gold standard, making the approach suitable for therapeutic drug monitoring in ambulatory and clinical care.
Development and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS — Opitz et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- oncology
2022
Capillary VAMS combined with direct mercury analysis demonstrated strong correlation with venous blood mercury concentrations in adult volunteers, with acceptable accuracy and precision above 1.0 µg/l. Storage in pre-cleaned glass vials following two hours of desiccator drying maintained analyte stability for at least four weeks.
Mercury biomonitoring in German adults using volumetric absorptive microsampling — Koutsimpani-Wagner et al., Environmental monitoring and assessment
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- toxicology
2022
Finger-prick VAMS sampling gives results that agree well with venous blood for paracetamol and three of its four metabolites, offering a less burdensome method for pharmacokinetic studies in obese and non-obese patients. Concentrations of APAP-cysteine in dried blood require careful interpretation, as this metabolite showed the largest differences between capillary and venous samples.
Application of a Volumetric Absorptive Microsampling (VAMS)-Based Method for the Determination of Paracetamol and Four of its Metabolites as a Tool for Pharmacokinetic Studies in Obese and Non-Obese Patients — Boffel et al., Clinical pharmacokinetics (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
2022
Volumetric absorptive microsampling with mass spectrometry correlated well with reference methods for haemoglobin A1c, but imprecision fell short of clinical quality standards. The platform successfully identified haemoglobin variants, indicating promise for decentralised proteomic testing while requiring precision improvements for routine use.
Evaluation of Volumetric Absorptive Microsampling and Mass Spectrometry Data-Independent Acquisition of Hemoglobin-Related Clinical Markers — Lima et al., Journal of proteome research (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- biomarkers
2022
Researchers validated an LC-MS/MS method for measuring 5-fluorouracil, capecitabine and metabolites from Neoteryx Mitra VAMS devices, achieving acceptable precision (3.0–8.1% intra-day, 6.3–13.3% inter-day) and accuracy (95–114%). Enabling at-home blood collection for therapeutic drug monitoring could reduce toxicity and improve outcomes in oncology patients by supporting individualised dosing.
Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS — Radovanovic et al., Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- oncology
2022
The study validated dried microsampling methods for clozapine therapeutic drug monitoring using VAMS and microfluidic blood spot devices. With extraction yields around 85% and satisfactory precision, these approaches could support decentralised monitoring of psychiatric patients, improving compliance and safety.
Dried Volumetric Microsampling Approaches for the Therapeutic Drug Monitoring of Psychiatric Patients Undergoing Clozapine Treatment — Marasca et al., Frontiers in psychiatry
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- tdm
2022
The study validated an LC-MS/MS method for measuring eight tyrosine kinase inhibitors in dried blood samples collected via VAMS, showing good accuracy, precision and haematocrit independence. It demonstrated agreement with venous sampling, supporting the use of decentralised, patient-centric microsampling for oncology drug monitoring.
Volumetric absorptive microsampling as a suitable tool to monitor tyrosine kinase inhibitors — Verougstraete & Stove, Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- oncology
- haematocrit
2022
The study validated a method to measure cannabidiol, THC and their metabolites in small blood samples collected via VAMS from epilepsy patients, showing it is suitable for therapeutic drug monitoring in a decentralised setting using a virtually painless technique.
Cannabidiol, ∆<sup>9</sup>-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients — Pigliasco et al., Frontiers in pharmacology
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- toxicology
2022
LC-MS/MS assay validation for monitoring tacrolimus and creatinine in renal transplant patients demonstrated that volumetric absorptive microsampling is the preferred single-sampling approach compared to traditional dried blood spots and venous sampling.
Analytical and clinical validation of dried blood spot and volumetric absorptive microsampling for measurement of tacrolimus and creatinine after renal transplantation — Mathew et al., Clinical biochemistry (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2021
Fully remote, home-collected fingerstick Mitra VAMS samples from 54 participants measured IgG/IgA/IgM against spike and nucleocapsid across seven coronaviruses, cleanly separating pre-pandemic, convalescent and vaccinated groups, supporting VAMS for at-home serosurveillance.
Antibody-mediated immunity to SARS-CoV-2 and human coronaviruses: multiplex beads assay and VAMS to generate immune-repertoire cartography — Wang et al., Frontiers in Immunology
- blood
- dried
- vams
- neoteryx-mitra
- serology
- self-collection
2021
This review found that decentralised, patient-centric home microsampling using Mitra devices is an effective alternative for COVID-19 serosurveillance and clinical trials, enabling high-quality self-collection without clinic visits.
Volumetric absorptive microsampling: its use in COVID-19 research and testing — Rudge, Bioanalysis
- blood
- dried
- vams
- neoteryx-mitra
- serology
- self-collection
- validation
2021
In paediatric inflammatory bowel disease patients, infliximab levels measured from dried capillary blood spots strongly correlated with venous serum concentrations, with a mean difference of -0.14 μg/mL and excellent interclass correlation coefficient of 0.998. This demonstrates that finger-prick microsampling is a patient-friendly alternative to venepuncture for therapeutic drug monitoring of biologics in children.
Infliximab Level Between Venous and Capillary Blood Using Novel Device Strongly Correlate in Paediatric Inflammatory Bowel Disease Patients — Zijlstra et al., Journal of pediatric gastroenterology and nutrition (paywalled)
- blood
- dried
- capillary
- neoteryx-mitra
- venous-agreement
- pediatric
- tdm
- biologics
2021
The study validated UPLC-MS/MS methods for both dried blood spot and volumetric absorptive microsampling to quantify tamoxifen and three metabolites in breast cancer patients, finding that VAMS extraction recovery was slightly higher than DBS while both showed satisfactory recovery with low variability, samples were stable for two months, and mean patient concentrations did not differ significantly between the two methods. This supports decentralised therapeutic drug monitoring of tamoxifen using either microsampling format.
Analysis of tamoxifen and its metabolites in dried blood spot and volumetric absorptive microsampling: comparison and clinical application — Maggadani et al., Heliyon
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- tdm
- oncology
2021
The study validated a VAMS-based LC-MS/MS method for measuring tamoxifen and its active metabolites in breast cancer patients, showing good accuracy, precision and stability at room temperature for 30 days. This supports decentralised therapeutic drug monitoring in oncology by enabling reliable, patient-collected sampling.
Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients — Maggadani et al., Drug design, development and therapy
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- oncology
2021
The study found that daclizumab and trastuzumab showed encouraging recovery from VAMS after short term storage at room temperature and long term storage at -80 degrees Celsius, supporting the use of VAMS for therapeutic drug monitoring of biologics in decentralised settings.
Whole blood stability evaluation of monoclonal antibody therapeutics using volumetric absorptive microsampling — Li et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- biologics
2021
The study validated a sensitive LC-MS/MS method to measure rosuvastatin in 10 µL of blood collected using VAMS, with acceptable accuracy and precision across multiple days. Rosuvastatin remained stable in VAMS samples for 10 days at room temperature without pH buffer, supporting its use in decentralised clinical trials and patient-centric therapeutic drug monitoring.
Validation of LC-MS/MS method for determination of rosuvastatin concentration in human blood collected by volumetric absorptive microsampling (VAMS) — Moon et al., Translational and clinical pharmacology
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
2021
Volumetric absorptive microsampling with Mitra devices permits minimally invasive, finger-prick blood collection for therapeutic drug monitoring of antiseizure medications without trained staff. The review concluded that stability, accuracy and precision are acceptable for specific drugs and haematocrit effects are minimised, but evidence is drug-specific and further validation is required for decentralised clinical use.
Therapeutic Drug Monitoring of Antiseizure Medications Using Volumetric Absorptive Microsampling: Where Are We? — D'Urso et al., Pharmaceuticals
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- haematocrit
2021
Dried capillary blood collected with volumetric absorptive microsampling provides linear agreement with serum for lamotrigine, lacosamide and levetiracetam, enabling conversion factors to estimate serum trough concentrations for therapeutic drug monitoring.
Therapeutic Drug Monitoring of Lamotrigine, Lacosamide, and Levetiracetam in Dried Capillary Blood-Determination of Conversion Factors for Serum-Based Reference Ranges — Klimpel et al., Therapeutic drug monitoring (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
2021
The study validated a VAMS method for measuring ten antihypertensive drugs in finger prick blood, showing acceptable accuracy and precision for most analytes, though concentrations in VAMS samples cannot be used interchangeably with plasma and require specific reference ranges. This supports decentralised therapeutic drug monitoring using patient-centric microsampling.
Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS — Jacobs et al., Analytica chimica acta (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
2021
The study developed and validated an LC-MS/MS method for moxidectin and showed that capillary Mitra® microsampling in Strongyloides-infected adults yielded pharmacokinetic profiles in close agreement with venous sampling, with identical time to maximal concentration of 4.0 hours and similar maximal concentrations of 83.9–88.5 ng/mL. This demonstrates the method and device are suitable for therapeutic drug monitoring of anthelmintics in decentralised field settings.
Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos — Hofmann et al., Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
2021
VAMS coupled with LC-MS/MS showed good correlation with conventional serum sampling for monoclonal antibody pharmacokinetics in rhesus monkeys, but a subsequent clinical study revealed that EDTA anticoagulant in standard and quality control samples caused anomalous internal standard responses in patient fingerstick samples, compromising accuracy. The authors recommend specific best practices during method development and validation to detect such anticoagulant effects early before deploying VAMS in clinical studies.
Volumetric absorptive microsampling (VAMS®) in therapeutic protein quantification by LC-MS/MS: Investigation of anticoagulant impact on assay performance and recommendations for best practices in method development — Gao et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- biologics
2021
The study compared VAMS capillary finger prick samples with venous liquid and venous VAMS samples from 50 healthy volunteers for thiamine diphosphate measurement, finding 94 to 100 per cent of results within 20 per cent of their mean across all comparisons with no significant bias. VAMS microsamples also remained stable when sent through regular post without affecting results, supporting their use for decentralised thiamine status assessment in both developed and remote settings.
Volumetric absorptive microsampling (VAMS) as a reliable tool to assess thiamine status in dried blood microsamples: a comparative study — Verstraete & Stove, The American journal of clinical nutrition (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- dct
- biomarkers
2021
Capillary blood collected by fingerstick with the Mitra volumetric absorptive microsampling device showed near identical sensitivity and specificity for SARS-CoV-2 antibodies compared with venous serum when analysed with the Roche Elecsys assay. This validation enables decentralised, patient-centric serology testing for remote or at-home use and large-scale community seroprevalence studies.
Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing — Garcia-Beltran et al., Archives of pathology & laboratory medicine (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- self-collection
- validation
- venous-agreement
- serology
2021
This proof-of-concept study compared VAMS and dried blood spot microsamples with fluid blood for untargeted lipidomic profiling using high-resolution LC-MS/MS, finding that VAMS is a viable option for untargeted lipidomics with the advantage of haematocrit independence over traditional dried blood spots.
Volumetric Absorptive Microsampling of Blood for Untargeted Lipidomics — Marasca et al., Molecules
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- haematocrit
- biomarkers
2021
Capillary blood collected with the Neoteryx Mitra device showed a high correlation with venous samples for tacrolimus monitoring in transplant recipients, but yielded concentrations that were on average 22.5% higher. This minimally invasive method offers a convenient alternative to venepuncture for therapeutic drug monitoring, provided the consistent positive bias is accounted for in clinical interpretation.
Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients — Undre et al., Therapeutic drug monitoring
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2021
The authors developed and fully validated LC-MS/MS methods for paracetamol and four metabolites in plasma, whole blood and 10 microlitre VAMS dried blood microsamples, including assessment of haematocrit effects on VAMS recovery. Successful analysis of patient samples collected from both venous and capillary blood confirmed the methods are fit for purpose and can support future pharmacokinetic studies using decentralised microsampling.
Determination of paracetamol and its metabolites via LC-MS/MS in dried blood volumetric absorptive microsamples: A tool for pharmacokinetic studies — Delahaye et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- tdm
- haematocrit
2021
A bioanalytical method for tacrolimus quantitation from MITRA capillary blood samples met all FDA and EMA validation criteria, showing accuracy and precision across 1–50 ng/mL. Haematocrit and hyperlipidaemia did not affect quantitation, and samples remained stable for up to 96 days, supporting minimally invasive therapeutic drug monitoring from a fingerprick.
Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device — Undre et al., Therapeutic drug monitoring
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- immunosuppressants
2021
This review summarises liquid chromatography with tandem mass spectrometry assays using dried blood spots and volumetric absorptive microsampling for quantifying antimicrobial drugs in children, highlighting that VAMS reduces haematocrit bias and offers a viable alternative to traditional plasma sampling for therapeutic drug monitoring.
Microsampling Assays for Pharmacokinetic Analysis and Therapeutic Drug Monitoring of Antimicrobial Drugs in Children: A Critical Review — Moorthy et al., Therapeutic drug monitoring (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- pediatric
- tdm
- antimicrobials
- haematocrit
2021
A quantitative VAMS method for PEth 16:0/18:1 was developed and validated across two laboratories, showing good comparability (average bias −0.4%, 85% of differences within 20%) and reproducibility over one year; this supports reliable decentralised alcohol monitoring using finger‑prick dried blood microsamples.
Quantitation of phosphatidylethanol in dried blood after volumetric absorptive microsampling — Van Uytfanghe et al., Talanta (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- toxicology
2021
Two feasibility studies assessed low-volume blood sampling for therapeutic drug monitoring. In patients receiving an anti-A therapeutic, drug levels were measured from finger-prick whole blood collected with Neoteryx Mitra and from capillary plasma collected with TASSO OnDemand, and compared with venipuncture samples. The work outlines practical considerations for adopting these patient-centric microsampling methods in decentralised trials and clinical care.
Assessment of low volume sampling technologies: utility in nonclinical and clinical studies — Williams et al., Bioanalysis (paywalled)
- blood
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- biologics
2021
The HPLC-MS/MS assay on dried capillary blood collected with VAMS was linear, precise and stable, and showed strong agreement with liquid venous tacrolimus measurements, supporting its use for therapeutic drug monitoring in transplant recipients.
Volumetric absorptive microsampling for the quantification of tacrolimus in capillary blood by high performance liquid chromatography-tandem mass spectrometry — Tron et al., Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2020
Fingerprick blood collected with Neoteryx Mitra devices showed minimal bias compared to venous sampling for tacrolimus (-5.6%) and creatinine (-6.5%) in renal transplant patients. This validated method could enable home-based therapeutic drug monitoring and kidney function testing, reducing the need for hospital visits.
Assessment of tacrolimus and creatinine concentration collected using Mitra microsampling devices — Marshall et al., Annals of clinical biochemistry (paywalled)
- blood
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2020
The study developed and validated an LC-MS/MS method to measure selumetinib in whole blood collected via VAMS, showing the approach is reliable and stable under various conditions. This supports decentralised therapeutic drug monitoring, particularly in paediatric populations where less invasive sampling is beneficial.
Novel LC-MS/MS method for the determination of selumetinib (AZD6244) in whole blood collected with volumetric absorptive microsampling — Voggu et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- pediatric
- tdm
2020
The authors developed and validated high-sensitivity LC-MS/MS methods for tranexamic acid quantification in human whole blood, using either liquid samples or dried samples on volumetric absorptive microsampling devices. The methods performed excellently across clinically relevant concentrations, showed stability for up to one month at +50°C, and were validated with clinical samples, supporting decentralised therapeutic drug monitoring of this antifibrinolytic.
Tranexamic acid quantification in human whole blood using liquid samples or volumetric absorptive microsampling devices — Lamy et al., Bioanalysis (paywalled)
- blood
- liquid
- dried
- vams
- neoteryx-mitra
- validation
- tdm
2020
A VAMS method for measuring gamma-hydroxybutyric acid in blood was fully validated, showing linearity from 0.5 to 200 μg/ml and a lower limit of quantitation of 0.5 μg/ml. The method compared well with conventional plasma analysis in a patient receiving GHB therapy, suggesting microsampling could support decentralised therapeutic drug monitoring for this compound.
Development and validation of volumetric absorptive microsampling coupled with UHPLC-MS/MS for the analysis of gamma-hydroxybutyric acid in human blood — Mohamed et al., Biomedical chromatography : BMC (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
2020
An LC-MS/MS assay for testosterone, androstenedione and 17-hydroxyprogesterone using Mitra microsampling devices achieved mean recoveries of 102%, 98% and 97% respectively, with limits of quantification of 1–4 nmol/L. This analytical validation demonstrates that volumetric absorptive microsampling can deliver reliable reproductive hormone measurements, supporting its use in decentralised diagnostics.
Quantification of testosterone, androstenedione and 17-hydroxyprogesterone in whole blood collected using Mitra microsampling devices — Marshall et al., Annals of clinical biochemistry (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- fertility
- hormones
2020
In children with epilepsy in remote African settings, dried blood microsampling enabled therapeutic drug monitoring but showed most patients had subtherapeutic antiepileptic drug concentrations. Volumetric absorptive microsampling gave inexplicably higher results than dried blood spots, and drug levels did not correlate with seizure control.
Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo — Velghe et al., Therapeutic drug monitoring (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- pediatric
- tdm
2020
Capillary blood collected with Neoteryx Mitra VAMS microsampling devices can quantify IGF-1 by automated chemiluminescent immunoassay after aqueous extraction. The hormone is stable for at least one month at room temperature, and dried blood concentrations match serum after dilution correction, though capillary samples underestimate high serum values, supporting patient-centric, decentralised endocrine monitoring but requiring population-specific reference ranges.
Volumetric Absorptive Microsampling (VAMS) technology for IGF-1 quantification by automated chemiluminescent immunoassay in dried blood — Marchand et al., Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- hormones
2020
The authors developed and validated a volumetric absorptive microsampling assay for vancomycin in whole blood that is suitable for paediatric therapeutic drug monitoring. Vancomycin remained stable in dried VAMS samples for at least 160 days at -78°C, enabling reliable quantification in clinical studies using minimal blood volumes.
A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study — Moorthy et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- pediatric
- tdm
- antimicrobials
2020
A VAMS method for 14 antidepressants, antipsychotics and active metabolites was validated on HPLC-MS and conversion factors from capillary blood to plasma were derived from 49 patient samples using Passing-Bablok and Bland-Altman analysis, enabling routine therapeutic drug monitoring.
Validation and clinical application of a volumetric absorptive microsampling method for 14 psychiatric drugs — Stern et al., Bioanalysis (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- tdm
2020
The study developed and validated a LC-HRMS method for intact IGF-I from VAMS dried blood according to World Anti-Doping Agency requirements and showed agreement with serum measurements, supporting decentralised sampling for antidoping testing.
Use of capillary dried blood for quantification of intact IGF-I by LC-HRMS for antidoping analysis — Mongongu et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- doping
2020
Capillary blood sampling using volumetric absorptive microsampling demonstrated non-significant differences in cannabidiol concentrations compared to venous blood and plasma in pediatric patients treated with Epidiolex. The method requires 30 µL of sample, achieves linear quantification between 1 and 800 µg/L, and ensures analyte stability on VAMS devices for up to four weeks at room temperature.
Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation — Pigliasco et al., Molecules
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- pediatric
- tdm
2020
The Mitra microsampling device showed high clinical concordance with venous blood for tacrolimus (89%) and cyclosporin A (98%) monitoring, with inter- and intra-precision within 11.5% CV and samples stable for up to 7 days at room temperature. Transplant patients preferred collecting capillary samples at home for their immunosuppressant monitoring, supporting decentralised TDM.
Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction — Mbughuni et al., The journal of applied laboratory medicine (paywalled)
- blood
- capillary
- vams
- volumetric
- neoteryx-mitra
- validation
- venous-agreement
- acceptability
- tdm
- immunosuppressants
2020
The authors developed two simple methods to calculate haematocrit from VAMS samples using potassium content, one with aqueous extraction and one with organic extraction, both designed to integrate with existing VAMS assays so that whole-blood results can be converted to serum or plasma values and compared with therapeutic intervals.
Hematocrit prediction in volumetric absorptive microsamples — Capiau & Stove, Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- haematocrit
2020
The study validated a VAMS-based bioanalytical method using the Tasso OnDemand device for the drug gefapixant and demonstrated a mathematical bridging relationship with standard plasma assays, supporting its use in decentralised clinical trials.
Clinical application of volumetric absorptive microsampling to the gefapixant development program — Roadcap et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
2020
Capillary microsampling using the Neoteryx Mitra device predicted tacrolimus AUC with high accuracy and precision compared with venous sampling in renal transplant recipients, with 85% of estimates within ±11.9% error. Patients could self-sample accurately at home, enabling patient-centred therapeutic drug monitoring without extended hospital stays.
Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling — Gustavsen et al., Therapeutic drug monitoring (paywalled)
- blood
- capillary
- vams
- neoteryx-mitra
- self-collection
- validation
- venous-agreement
- tdm
- immunosuppressants
2020
The study developed and validated a VAMS-based method for measuring cefepime in small volumes of paediatric blood with high accuracy and precision, enabling less invasive therapeutic drug monitoring in children. This advances decentralised, patient-centric sampling by allowing reliable pharmacokinetic studies without repeated venous draws.
Development and validation of a volumetric absorptive microsampling- liquid chromatography mass spectrometry method for the analysis of cefepime in human whole blood: Application to pediatric pharmacokinetic study — Moorthy et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- pediatric
- tdm
- antimicrobials
2020
The review highlights that volumetric absorptive microsampling enables easy, minimally invasive home sampling with room temperature storage and fixed volume accuracy, making it a viable alternative for clinical trials and therapeutic drug monitoring during the COVID-19 pandemic.
Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review — Harahap et al., Drug design, development and therapy
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- dct
- haematocrit
2020
The study validated a VAMS method for cocaine and metabolites in blood and plasma, achieving good extraction yield, precision and accuracy with analyte stability exceeding two months at room temperature. Results from VAMS correlated well with conventional fluid samples, supporting its use for decentralised forensic and toxicological monitoring without venepuncture or cold chain.
Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption — Mandrioli et al., Molecules
- blood
- dried
- vams
- neoteryx-mitra
- validation
- doping
- toxicology
2019
The authors developed and validated an LC-MS/MS assay for THC, CBD and CBN from 20 µL VAMS blood samples with linear calibration curves and inter-day accuracies of 94.4 to 107 per cent, then applied it to a pediatric pharmacokinetic study, demonstrating that patient-centric microsampling can support decentralised therapeutic drug monitoring of cannabinoids in children.
A patient-centric liquid chromatography-tandem mass spectrometry microsampling assay for analysis of cannabinoids in human whole blood: Application to pediatric pharmacokinetic study — Moorthy et al., Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- pediatric
- tdm
2019
HPLC-MS/MS methods for midazolam and 1-OH midazolam in wet whole blood and dried blood collected on VAMS were developed and validated, meeting international guideline criteria; a strong correlation between wet and dry concentrations was observed, indicating VAMS is suitable for paediatric clinical studies.
Validation of methods for determining pediatric midazolam using wet whole blood and volumetric absorptive microsampling — Abu-Rabie et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- venous-agreement
- pediatric
- tdm
2019
Volumetric absorptive microsampling (VAMS) using the Neoteryx Mitra device was validated for mitotane therapeutic drug monitoring across 1–50 mg/L, with acceptable haematocrit bias and one-week stability at room temperature. However, comparison with venous plasma showed poor correlation, suggesting home-based VAMS is of limited clinical value for mitotane unless a method-specific target range is established.
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring — Friedl et al., Analytical and bioanalytical chemistry (paywalled)
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- oncology
2019
The study developed and validated two LC-MS/MS methods for quantifying paracetamol in dried blood and dried cerebrospinal fluid using VAMS, showing acceptable precision and accuracy, limited haematocrit influence, and stability under various storage conditions, thus proving the utility of VAMS for CSF microsampling.
Volumetric absorptive microsampling as an alternative sampling strategy for the determination of paracetamol in blood and cerebrospinal fluid — Delahaye et al., Analytical and bioanalytical chemistry (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- haematocrit
2019
Microsampling with the Neoteryx Mitra device showed acceptable linearity and precision for cyclosporine A, everolimus, sirolimus and tacrolimus, and agreed closely with conventional venous extraction by Deming regression, supporting its use for decentralised immunosuppressant therapeutic drug monitoring.
Feasibility of Immunosuppressant Drug Monitoring by a Microsampling Device — Gruzdys et al., The journal of applied laboratory medicine (paywalled)
- blood
- vams
- neoteryx-mitra
- validation
- venous-agreement
- tdm
- immunosuppressants
2019
In ten healthy volunteers, radiprodil pharmacokinetics measured by Aqua-Cap™ Drummond microsampling closely matched conventional venous blood draws, whereas Mitra™ microsampling gave marginally lower exposure values. Both microsampling methods fell within the accepted bioequivalence range, indicating they could enable patient-centric therapeutic drug monitoring and future paediatric decentralised trials.
A pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniques — Sciberras et al., Pharmacology research & perspectives
- blood
- capillary
- vams
- neoteryx-mitra
- validation
- venous-agreement
- pediatric
2019
VAMS capillary blood showed strong agreement with venous serum for measuring anti-influenza antibodies and remained stable for three weeks at room temperature. When volunteers performed finger-stick sampling at home, their results were highly consistent with on-site collection by study personnel.
Application of volumetric absorptive microsampling (VAMS) to measure multidimensional anti-influenza IgG antibodies by the mPlex-Flu assay — Wang et al., Journal of clinical and translational science
- blood
- dried
- capillary
- vams
- neoteryx-mitra
- self-collection
- validation
- venous-agreement
- serology
2019
The VAMS assay quantifies voriconazole and voriconazole N-oxide with linear calibration from 10.0 to 10,000 ng/mL and intra- and inter-day accuracy within 87-102%, enabling accurate and precise therapeutic drug monitoring from a small fixed volume of dried blood.
Development and validation of a volumetric absorptive microsampling assay for analysis of voriconazole and voriconazole N-oxide in human whole blood — Moorthy et al., Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- antimicrobials
2019
The validated LC-MS/MS method showed similar pharmacokinetic profiles for albendazole and its metabolites across plasma, whole blood, dried blood spots and Mitra microsamples from hookworm-infected adolescents, supporting microsampling for paediatric pharmacokinetic studies. Mitra extraction proved more robust than dried blood spots during validation and is recommended for future albendazole pharmacokinetic work, despite higher albendazole sulfone concentrations observed in both microsampling devices compared with wet matrices.
Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents — Schulz et al., Antimicrobial agents and chemotherapy (paywalled)
- blood
- liquid
- dried
- capillary
- vams
- dbs
- neoteryx-mitra
- validation
- venous-agreement
- pediatric
- tdm
- antimicrobials
2019
The authors validated an LC-MS/MS method for simultaneously measuring vancomycin and creatinine from plasma applied to VAMS devices, reporting acceptable precision and accuracy with both analytes stable for up to two weeks at 45 degrees Celsius, though VAMS concentrations required correction factors to estimate plasma levels. This supports wider access to vancomycin therapeutic drug monitoring in resource-limited settings by enabling ambient transport of dried plasma microsamples.
Simultaneous determination of vancomycin and creatinine in plasma applied to volumetric absorptive microsampling devices using liquid chromatography-tandem mass spectrometry — Andriguetti et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- antimicrobials
2018
Acetylsalicylic acid concentrations in VAMS samples decrease without a stabilising reagent, whereas whole blood samples remain stable. For decentralised diagnostics, this means stabilisers must be added to VAMS devices before analysis to ensure accurate therapeutic drug monitoring from patient-collected samples.
Quantitative analysis of acetylsalicylic acid in human blood using volumetric absorptive microsampling — Kim et al., Translational and clinical pharmacology
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
2018
Volumetric absorptive microsampling provided acceptable analytical accuracy and precision for atenolol, lisinopril, simvastatin and capillary blood samples without being influenced by haematocrit levels. The VAMS approach demonstrated strong agreement with standard dried blood spot cards in identifying medication adherence among volunteers.
Volumetric absorptive microsampling (VAMS) coupled with high-resolution, accurate-mass (HRAM) mass spectrometry as a simplified alternative to dried blood spot (DBS) analysis for therapeutic drug monitoring of cardiovascular drugs — Tanna et al., Clinical mass spectrometry (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- tdm
- haematocrit
2018
Volumetric absorptive microsampling provided accurate and precise measurement of key urinary metabolites in alkaptonuria with good recovery and reproducibility, and dried samples compared favourably with liquid specimens, although variable analyte stability may present barriers to routine implementation.
Evaluation of the Mitra microsampling device for use with key urinary metabolites in patients with Alkaptonuria — Taylor et al., Bioanalysis (paywalled)
- urine
- dried
- vams
- neoteryx-mitra
- validation
2018
Capillary C-peptide concentrations measured from dried blood spot and volumetric absorptive microsampling showed strong agreement with reference plasma samples. Both sampling methods maintained stability over 48 hours at room temperature, supporting their utility for remote monitoring of endogenous insulin secretion.
Microsampling Collection Methods for Measurement of C-peptide in Whole Blood — Jones et al., Journal of diabetes science and technology (paywalled)
- blood
- dried
- capillary
- vams
- dbs
- neoteryx-mitra
- validation
- venous-agreement
2018
VAMS recovery relative to DMPK-C depended on the protein, being lower for β-lactoglobulin and myoglobin but higher for cytochrome c and albumin, and haematocrit affected protein quantification from both materials. VAMS showed strong correlation (R² ≥ 0.983), accuracy of 71 to 101 per cent and precision with RSD at or below 20 per cent for six model proteins spiked into blood, supporting its use for decentralised protein analysis with awareness of haematocrit effects.
Volumetric absorptive MicroSampling vs. other blood sampling materials in LC-MS-based protein analysis - preliminary investigations — Andersen et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- haematocrit
2017
In breast cancer patients, whole blood microsampling by dried matrix on paper discs and volumetric absorptive microsampling detected a similar number of metabolites with comparable reproducibility and group discrimination to the standard protein precipitation method, supporting their use as simpler alternatives in decentralised metabolomics workflows.
Comparative study on microsampling techniques in metabolic fingerprinting studies applying gas chromatography-MS analysis — Cala & Meesters, Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- metabolome
2017
A miniaturised stable isotope dilution assay using volumetric absorptive microsampling quantified whole blood 5-methyltetrahydrofolic acid from only 10.8 μL with good precision and reproducibility. The dried samples remained stable for three weeks at -20°C, demonstrating VAMS enables accurate folate status screening with minimal blood volume, which is valuable for population and newborn screening programmes.
Assessing Volumetric Absorptive Microsampling Coupled with Stable Isotope Dilution Assay and Liquid Chromatography-Tandem Mass Spectrometry as Potential Diagnostic Tool for Whole Blood 5-Methyltetrahydrofolic Acid — Kopp & Rychlik, Frontiers in nutrition
- blood
- dried
- vams
- neoteryx-mitra
- validation
- biomarkers
2017
VAMS devices collect accurate blood volumes regardless of haematocrit level, but conventional ultrasonication extraction showed reduced drug recovery at higher haematocrit. A new bead-based impact-assisted extraction eliminated this bias, achieving quantitative recovery of naproxen and ritonavir across all haematocrit levels tested.
Volumetric absorptive microsampling combined with impact-assisted extraction for hematocrit effect free assays — Youhnovski et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- haematocrit
2017
The study developed and validated an LC-MS/MS method for quantitating estetrol from 10–20 µL whole blood collected on volumetric absorptive microsampling devices, demonstrating selectivity, trueness, precision, accuracy and stability without derivatisation, and confirmed performance in murine pharmacokinetic studies; this enables reliable, low-volume microsampling for decentralised pharmacokinetic applications.
Whole blood microsampling for the quantitation of estetrol without derivatization by liquid chromatography-tandem mass spectrometry — Nys et al., Journal of pharmaceutical and biomedical analysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
2016
An LC-MS/MS method accurately quantified hydroxyurea from small volumes of dried blood collected on DMPK-C cards and VAMS devices across a linear range of 0.5 to 60 μg/mL with comparable performance. This enables therapeutic drug monitoring and pharmacokinetic assessment in pediatric sickle cell anemia patients using capillary heel- or finger-prick sampling.
Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood Samples — Marahatta et al., Clinical chemistry (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- pediatric
- tdm
2015
Combining volumetric absorptive microsampling with phospholipid removal plates reduces matrix effects and delivers high sensitivity for dried blood hepcidin quantification. This method establishes a reliable microsampling protocol to quantify this peptide hormone while mitigating haematocrit bias.
Hepcidin determination in dried blood by microfluidic LC-MS/MS: comparison of DBS and volumetric absorptive microsampling for matrix effect and recovery — Houbart et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- dbs
- neoteryx-mitra
- validation
- hormones
- haematocrit
2015
The authors validated an LC-MS/MS method for quantifying emixustat in whole blood collected by VAMS. The assay performed reliably across the normal adult haematocrit range and the analyte remained stable on the device under ambient, refrigerated, and frozen storage, enabling decentralised therapeutic drug monitoring without plasma separation or cold chain.
Bioanalysis of emixustat (ACU-4429) in whole blood collected with volumetric absorptive microsampling by LC-MS/MS — Miao et al., Bioanalysis (paywalled)
- blood
- dried
- vams
- neoteryx-mitra
- validation
- tdm
- haematocrit
2014
The foundational VAMS paper: a fixed ~10 µL is absorbed with under 5% volume variation across a 20–70% haematocrit range, overcoming the area bias and homogeneity problems of the dried blood spot.
Volumetric Absorptive Microsampling: A Dried Sample Collection Technique for Quantitative Bioanalysis — Denniff & Spooner, Analytical Chemistry (paywalled)
- vams
- neoteryx-mitra
- blood
- haematocrit
- dried
- validation
Read from the corpus on .